BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8335981)

  • 1. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans.
    Torosantucci A; Bromuro C; Gomez MJ; Ausiello CM; Urbani F; Cassone A
    J Infect Dis; 1993 Aug; 168(2):427-35. PubMed ID: 8335981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.
    Torosantucci A; Palma C; Boccanera M; Ausiello CM; Spagnoli GC; Cassone A
    J Gen Microbiol; 1990 Nov; 136(11):2155-63. PubMed ID: 1706757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans.
    Ausiello CM; Urbani F; Gessani S; Spagnoli GC; Gomez MJ; Cassone A
    Infect Immun; 1993 Oct; 61(10):4105-11. PubMed ID: 8406799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
    Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
    Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.
    Gomez MJ; Torosantucci A; Arancia S; Maras B; Parisi L; Cassone A
    Infect Immun; 1996 Jul; 64(7):2577-84. PubMed ID: 8698482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans.
    Torosantucci A; Gomez MJ; Bromuro C; Casalinuovo I; Cassone A
    J Med Vet Mycol; 1991; 29(6):361-72. PubMed ID: 1815028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans.
    Bromuro C; Torosantucci A; Gomez MJ; Urbani F; Cassone A
    J Med Vet Mycol; 1994 Dec; 32(6):447-59. PubMed ID: 7738727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.
    Nisini R; Romagnoli G; Gomez MJ; La Valle R; Torosantucci A; Mariotti S; Teloni R; Cassone A
    Infect Immun; 2001 Jun; 69(6):3728-36. PubMed ID: 11349037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures.
    La Sala A; Urbani F; Torosantucci A; Cassone A; Ausiello CM
    J Biol Regul Homeost Agents; 1996; 10(1):8-12. PubMed ID: 9049775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of IL-6 and tumour necrosis factor-alpha (TNF-alpha) by MP-F2-stimulated PMNL from HIV-infected subjects.
    Torosantucci A; Chiani P; Quinti I; Ausiello CM; Mezzaroma I; Cassone A
    Clin Exp Immunol; 1997 Mar; 107(3):451-7. PubMed ID: 9067516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.
    Gomez MJ; Maras B; Barca A; La Valle R; Barra D; Cassone A
    Infect Immun; 2000 Feb; 68(2):694-701. PubMed ID: 10639435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans.
    La Valle R; Sandini S; Gomez MJ; Mondello F; Romagnoli G; Nisini R; Cassone A
    Infect Immun; 2000 Dec; 68(12):6777-84. PubMed ID: 11083795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans.
    Levitz SM; North EA
    J Med Vet Mycol; 1997; 35(4):229-36. PubMed ID: 9292418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mannoprotein constituent of Candida albicans cooperates with antigen in the induction of a specific primary antibody response in cultures of human lymphocytes.
    Luzzati AL; Giacomini E; Torosantucci A; Giordani L; Cassone A
    J Biol Regul Homeost Agents; 1990; 4(4):142-9. PubMed ID: 2096599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody forming cells with specificity for Candida albicans mannoproteins in cultures of human peripheral blood lymphocytes.
    Giacomini E; Boccanera M; Giordani L; Cassone A; Luzzati AL
    J Immunol Methods; 1993 Sep; 164(2):203-11. PubMed ID: 7690375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.
    Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F
    Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
    Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M
    Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low responsiveness to Candida antigens in kidney transplant recipients.
    Ausiello CM; Spagnoli GC; Sconocchia G; Pisani F; Adorno D; Casciani CU
    Microbiologica; 1991 Oct; 14(4):325-32. PubMed ID: 1775088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
    Smeekens SP; Gresnigt MS; Becker KL; Cheng SC; Netea SA; Jacobs L; Jansen T; van de Veerdonk FL; Williams DL; Joosten LA; Dinarello CA; Netea MG
    Cytokine; 2015 Feb; 71(2):215-22. PubMed ID: 25461401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.